TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Derks M, Bakker RM, Stiggelbout AM, et al. Long-term morbidity and quality of life in cervical cancer survivors: a multicenter comparison between surgery and radiotherapy as primary treatment. Int J Gynecol Cancer. 2017;27(2):350–356.
   PubMed Web of Science ®Google Scholar
• White MC, Shoemaker ML, Benard VB. Cervical cancer screening and incidence by age: unmet needs near and after the stopping age for screening. Am J Prev Med. 2017;53(3):392–395.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhu L, Lu W, et al. Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer. World J Surg Oncol. 2013;11:301.
   PubMed Web of Science ®Google Scholar
• Yun JA, Huh JW, Kim HC, et al. Local recurrence after curative resection for rectal carcinoma: the role of surgical resection. Medicine. 2016;95(27):e3942.
   PubMed Web of Science ®Google Scholar
• Karlsson J, Dreifaldt AC, Mordhorst LB, et al. Differences in outcome for cervical cancer patients treated with or without brachytherapy. Brachytherapy. 2017;16(1):133–140.
   PubMed Web of Science ®Google Scholar
• Markt SC, Tang T, Cronin AM, et al. Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival. PLoS One. 2018;13(2):e0193047.
   PubMed Web of Science ®Google Scholar
• Demirtas B. Review of strategies in promoting attendance for cervical screening. Asian Pac J Cancer Prev. 2013;14(5):3263–3267.
   PubMedGoogle Scholar
• Mohanty G, Ghosh SN. Risk factors for cancer of cervix, status of screening and methods for its detection. Arch Gynecol Obstet. 2015;291(2):247–249.
   PubMed Web of Science ®Google Scholar
• Menderes G, Black J, Schwab CL, et al. Immunotherapy and targeted therapy for cervical cancer: an update. Expert Rev Anticancer Ther. 2016;16(1):83–98.
   PubMed Web of Science ®Google Scholar
• Gradíssimo A, Burk RD. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev Mol Diagn. 2017;17(4):379–391.
   PubMed Web of Science ®Google Scholar
• Franks TM, Benner C, Narvaiza I, et al. Evolution of a transcriptional regulator from a transmembrane nucleoporin. Genes Dev. 2016;30(10):1155–1171.
   PubMed Web of Science ®Google Scholar
• Jovanovic-Talisman T, Zilman A. Protein transport by the nuclear pore complex: simple biophysics of a complex biomachine. Biophys J. 2017;113(1):6–14.
   PubMed Web of Science ®Google Scholar
• Breuer M, Ohkura H. A negative loop within the nuclear pore complex controls global chromatin organization. Genes Dev. 2015;29(17):1789–1794.
   PubMed Web of Science ®Google Scholar
• Gu Y. The nuclear pore complex: a strategic platform for regulating cell signaling. New Phytol. 2018;219(1):25–30.
   PubMed Web of Science ®Google Scholar
• Köhler A, Hurt E. Gene regulation by nucleoporins and links to cancer. Mol Cell. 2010;38(1):6–15.
   PubMed Web of Science ®Google Scholar
• Wong RW, D'Angelo M. Linking nucleoporins, mitosis, and colon cancer. Cell Chem Biol. 2016;23(5):537–539.
   PubMed Web of Science ®Google Scholar
• Takeda A, Yaseen NR. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies. Semin Cancer Biol. 2014;27:3–10.
   PubMed Web of Science ®Google Scholar
• Stavru F, Hülsmann BB, Spang A, et al. NDC1: a crucial membrane-integral nucleoporin of metazoan nuclear pore complexes. J Cell Biol. 2006;173(4):509–519.
   PubMed Web of Science ®Google Scholar
• Mansfeld J, Güttinger S, Hawryluk-Gara LA, et al. The conserved transmembrane nucleoporin NDC1 is required for nuclear pore complex assembly in vertebrate cells. Mol Cell. 2006;22(1):93–103.
   PubMed Web of Science ®Google Scholar
• Akiyama K, Noguchi J, Hirose M, et al. A mutation in the nuclear pore complex gene Tmem48 causes gametogenesis defects in Skeletal Fusions with Sterility (sks) mice. J Biol Chem. 2013;288(44):31830–31841.
   PubMed Web of Science ®Google Scholar
• Qiao W, Han Y, Jin W, et al. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma. Tumour Biol. 2016;37(2):2575–2586.
   PubMedGoogle Scholar
• Ashihara E, Takada T, Maekawa T. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies. Cancer Sci. 2015;106(6):665–671.
   PubMed Web of Science ®Google Scholar
• Vilchez V, Turcios L, Marti F, et al. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol. 2016;22(2):823–832.
   PubMed Web of Science ®Google Scholar
• Sun X, Liu Y. Activation of the Wnt/β-catenin signaling pathway may contribute to cervical cancer pathogenesis via upregulation of Twist. Oncol Lett. 2017;14(4):4841–4844.
   PubMed Web of Science ®Google Scholar
• Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319–321.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Laversanne M, Ferlay J, et al. Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends. Int J Cancer. 2017;141(10):1997–2001.
   PubMed Web of Science ®Google Scholar
• Schmit K, Michiels C. TMEM proteins in cancer: a review. Front Pharmacol. 2018;9:1345
   PubMed Web of Science ®Google Scholar
• Vinothkumar KR, Henderson R. Structures of membrane proteins. Q Rev Biophys. 2010;43(1):65–158.
   PubMed Web of Science ®Google Scholar
• Hayez A, Malaisse J, Roegiers E, et al. High TMEM45A expression is correlated to epidermal keratinization. Exp Dermatol. 2014;23(5):339–344.
   PubMed Web of Science ®Google Scholar
• Hrašovec S, Hauptman N, Glavač D, et al. TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer. Dis Markers. 2013;34(2):93–104.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Song K, Zhang Y, et al. TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling. Cancer Manag Res. 2018;10:2419–2428.
   PubMed Web of Science ®Google Scholar
• Shen K, Wei Y, Yanhui Y, et al. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer. Biomed Pharmacother. 2018;104:576–581.
   PubMed Web of Science ®Google Scholar
• Van Camp JK, Beckers S, Zegers D, et al. Wnt signaling and the control of human stem cell fate. Stem Cell Rev Rep. 2014;10(2):207–229.
   PubMed Web of Science ®Google Scholar
• Rudnicki MA, Williams BO. Wnt signaling in bone and muscle. Bone. 2015;80:60–66.
   PubMed Web of Science ®Google Scholar
• Mohammed MK, Shao C, Wang J, et al. Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis. 2016;3(1):11–40.
   PubMed Web of Science ®Google Scholar
• Pai SG, Carneiro BA, Mota JM, et al. Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol. 2017;10(1):101.
   PubMedGoogle Scholar
• Chen X, Song X, Yue W, et al. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer. Oncotarget. 2015;6(17):15022–15034.
   PubMedGoogle Scholar
• Wang P, Li L, Li T. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma. J Cancer Res Ther. 2016;12(Supplement):C19–C22.
   PubMedGoogle Scholar
• Jamieson C, Sharma M, Henderson BR. Wnt signaling from membrane to nucleus: β-catenin caught in a loop. Int J Biochem Cell Biol. 2012;44(6):847–850.
   PubMed Web of Science ®Google Scholar
• Ormanns S, Neumann J, Horst D, et al. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling. Oncotarget. 2014;5(10):2999–3011.
   PubMedGoogle Scholar